553 related articles for article (PubMed ID: 9777749)
1. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
Rone JK; Lane AG; Grinkemeyer MD
Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
[TBL] [Abstract][Full Text] [Related]
2. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
3. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
4. Unusual presentation of multiple endocrine neoplasia type 2A in a patient with the C634R mutation of the RET-protooncogene.
Harzallah F; Barlier A; Feki M; Enjalbert A; Slimane H
Ann Endocrinol (Paris); 2008 Dec; 69(6):523-5. PubMed ID: 18752792
[TBL] [Abstract][Full Text] [Related]
5. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
[TBL] [Abstract][Full Text] [Related]
6. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
8. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
[TBL] [Abstract][Full Text] [Related]
9. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
Zirie M; Mohammed I; El-Emadi M; Haider A
Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P
J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961
[TBL] [Abstract][Full Text] [Related]
12. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
[TBL] [Abstract][Full Text] [Related]
13. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
14. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
16. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes.
Wells SA; Skinner MA
Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and genetic screening of an extended family with MEN2A.
Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
[TBL] [Abstract][Full Text] [Related]
20. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP
Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
